Skip to main content
. Author manuscript; available in PMC: 2017 Feb 5.
Published in final edited form as: J Vasc Surg. 2011 May 28;54(3):714–721. doi: 10.1016/j.jvs.2011.03.216

Table I. Demographics of patients undergoing revascularization for superficial femoral artery (SFA) occlusive disease.

Variablea Bypass SFA stent P
Total patients 141 204
Total limbs 152 233
Age, years 66 ± 22 (38-87) 70 ± 11 (37-99) .0013
Male sex 101 (66) 129 (55) .0302
Indication
 Claudication 70 (46) 130 (56) .0773
 CLI 82 (54) 103 (44)
Diabetes 64 (42) 105 (45) .5686
Creatinine >1.8 mg/dL 17 (11) 21 (9) .5594
Hypertension 115 (76) 192 (82) .0897
Hyperlipidemia 105 (69) 160 (69) .9813
Statin use 101 (66) 106 (55) .0197
Smoking 75 (49) 70 (30) <.0001
CAD 53 (35) 110 (47) .0165
TASC lesion <.0001
 A 3 (2) 41 (18)
 B 50 (33) 145 (62)
 C 33 (22) 32 (14)
 D 66 (43) 15 (6)

CAD, Coronary artery disease; CLI, critical limb ischemia; TASC, TransAtlantic Inter-Society Consensus.

a

Data are shown as number (%) or mean ± standard deviation (range).